Synvista Therapeutics, Inc. (SYNI)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Dec 30, 2025
Synvista Therapeutics Market Cap
Synvista Therapeutics has a market cap or net worth of $3 as of November 3, 2026. It is the 53,396th most valuable company in the world and the 9,322nd biggest in the United States. Its market cap has decreased by 98.84% in one year.
Market Cap
3.00
Enterprise Value
n/a
Revenue
54.73K
Global Rank
Country Rank
#9,322 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since November 1, 1991, Synvista Therapeutics's market cap has decreased from 330.80M to 3.00, a decrease of -100.00%. That is a compound annual growth rate of -41.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 3.00 | - |
| Dec 30, 2020 | 3.00 | -88.46% |
| Dec 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 1.19B |
| Veradigm | 851.43M |
| American Oncology Network | 746.52M |
| Nika Pharmaceuticals | 369.14M |
| Biora Therapeutics | 4.00 |
| Assure Holdings | 4.00 |
| Ormand Industries | 4.00 |
| Biocept | 3.00 |